$308 Million is the total value of DAFNA Capital Management LLC's 80 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $48,976,000 | -19.7% | 13,680,554 | 0.0% | 15.92% | -9.6% | |
| IMMU | Buy | IMMUNOMEDICS INC | $22,185,000 | +149.5% | 260,905 | +4.0% | 7.21% | +181.1% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $21,607,000 | +21.4% | 233,089 | +2.2% | 7.02% | +36.8% |
| FATE | Sell | FATE THERAPEUTICS INC | $17,525,000 | +4.1% | 438,460 | -10.7% | 5.70% | +17.2% |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDG I | $9,852,000 | +41.5% | 229,652 | +54.1% | 3.20% | +59.4% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $9,676,000 | +40.8% | 158,306 | -4.2% | 3.14% | +58.6% |
| DXCM | DEXCOM INC | $8,714,000 | +1.7% | 21,138 | 0.0% | 2.83% | +14.6% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $8,674,000 | -2.9% | 90,208 | +23.2% | 2.82% | +9.4% |
| DRNA | DICERNA PHARMACEUTICALS INC | $8,172,000 | -29.2% | 454,236 | 0.0% | 2.66% | -20.2% | |
| IBB | Buy | ISHARES TR NASDAQ BIOTECHetf | $7,569,000 | +0.9% | 55,900 | +1.8% | 2.46% | +13.6% |
| GLPG | GALAPAGOS NVspon adr | $6,297,000 | -28.1% | 44,375 | 0.0% | 2.05% | -19.0% | |
| CSII | CARDIOVASCULAR SYSTEMS INC | $5,950,000 | +24.7% | 151,200 | 0.0% | 1.93% | +40.5% | |
| PRQR | PROQR THERAPEUTICS N V | $5,927,000 | -21.2% | 1,237,400 | 0.0% | 1.93% | -11.2% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $5,670,000 | -63.3% | 75,815 | -69.1% | 1.84% | -58.6% |
| BHVN | Sell | BIOHAVEN PHARMACEUTICALS HOLD | $5,500,000 | -14.1% | 84,600 | -3.4% | 1.79% | -3.2% |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $5,322,000 | -17.2% | 1,095,139 | -5.7% | 1.73% | -6.8% |
| ATRC | ATRICURE INC | $5,316,000 | -11.2% | 133,229 | 0.0% | 1.73% | 0.0% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $4,512,000 | +114.2% | 29,237 | +105.4% | 1.47% | +141.3% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $4,166,000 | – | 331,661 | +100.0% | 1.35% | – |
| LMNX | LUMINEX CORP | $4,045,000 | -19.3% | 154,091 | 0.0% | 1.32% | -9.1% | |
| XENE | XENON PHARMACEUTICALS INC | $3,836,000 | -11.7% | 346,535 | 0.0% | 1.25% | -0.6% | |
| CNST | Buy | CONSTELLATION PHARMACEUTICAL | $3,666,000 | -28.6% | 180,942 | +5.8% | 1.19% | -19.6% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $3,348,000 | -18.8% | 284,440 | +1.8% | 1.09% | -8.6% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,315,000 | +10.9% | 4,000,000 | 0.0% | 1.08% | +24.9% | ||
| CARA | Sell | CARA THERAPEUTICS INC | $3,148,000 | -50.4% | 247,377 | -33.3% | 1.02% | -44.1% |
| AFMD | Buy | AFFIMED NV | $3,133,000 | -19.7% | 924,278 | +9.4% | 1.02% | -9.6% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $2,844,000 | -55.0% | 152,763 | -43.5% | 0.92% | -49.3% |
| ETNB | Buy | 89BIO INC | $2,835,000 | +594.9% | 110,478 | +439.5% | 0.92% | +681.4% |
| LQDA | Buy | LIQUIDIA TECHNOLOGIES INC | $2,829,000 | -38.9% | 575,000 | +4.5% | 0.92% | -31.1% |
| OTIC | Buy | OTONOMY INC | $2,791,000 | +64.4% | 689,100 | +46.9% | 0.91% | +85.1% |
| BEAT | BIOTELEMETRY INC | $2,758,000 | +0.9% | 60,500 | 0.0% | 0.90% | +13.7% | |
| VKTX | VIKING THERAPEUTICS INC | $2,624,000 | -19.3% | 450,900 | 0.0% | 0.85% | -9.1% | |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $2,619,000 | -2.7% | 208,054 | -6.5% | 0.85% | +9.5% |
| TBIO | New | TRANSLATE BIO INC | $2,599,000 | – | 190,930 | +100.0% | 0.84% | – |
| ARAY | Buy | ACCURAY INC | $2,578,000 | +88.3% | 1,074,300 | +59.3% | 0.84% | +112.2% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $2,573,000 | -27.4% | 749,051 | +0.7% | 0.84% | -18.3% |
| STIM | NEURONETICS INC | $2,409,000 | +151.7% | 495,772 | 0.0% | 0.78% | +183.7% | |
| KDMN | Buy | KADMON HOLDINGS INC | $2,209,000 | -22.1% | 563,564 | +1.8% | 0.72% | -12.2% |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $2,101,000 | – | 514,891 | +100.0% | 0.68% | – |
| MEIP | Buy | MEI PHARMA INC | $2,078,000 | +815.4% | 666,000 | +1110.9% | 0.68% | +922.7% |
| CGEN | Sell | COMPUGEN LTDord | $1,872,000 | -63.7% | 115,202 | -66.4% | 0.61% | -59.0% |
| ISEE | Sell | IVERIC BIO INC | $1,819,000 | -0.2% | 322,500 | -9.8% | 0.59% | +12.4% |
| BLUE | BLUEBIRD BIO INC | $1,633,000 | -11.6% | 30,273 | 0.0% | 0.53% | -0.4% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $1,516,000 | -71.6% | 102,713 | -71.5% | 0.49% | -68.0% |
| ALEC | ALECTOR INC | $1,475,000 | -56.9% | 140,000 | 0.0% | 0.48% | -51.5% | |
| HARP | HARPOON THERAPEUTICS INC | $1,446,000 | +2.3% | 85,119 | 0.0% | 0.47% | +15.2% | |
| JNJ | JOHNSON AND JOHNSON | $1,399,000 | +5.8% | 9,400 | 0.0% | 0.46% | +19.1% | |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $1,303,000 | – | 148,260 | +100.0% | 0.42% | – |
| RCUS | ARCUS BIOSCIENCES INC | $1,236,000 | -30.7% | 72,100 | 0.0% | 0.40% | -21.9% | |
| New | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,206,000 | – | 1,500,000 | +100.0% | 0.39% | – | |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $1,201,000 | -26.0% | 79,155 | -37.3% | 0.39% | -16.7% |
| KURA | Sell | KURA ONCOLOGY INC | $1,196,000 | -75.1% | 39,019 | -86.7% | 0.39% | -71.9% |
| STRO | Buy | SUTRO BIOPHARMA INC | $1,195,000 | +44.7% | 118,940 | +11.7% | 0.39% | +63.0% |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $1,125,000 | -23.7% | 320,542 | 0.0% | 0.37% | -13.9% | |
| SPRO | New | SPERO THERAPEUTICS INC | $1,116,000 | – | 100,000 | +100.0% | 0.36% | – |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $1,008,000 | – | 161,507 | +100.0% | 0.33% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $907,000 | -17.2% | 30,054 | -10.4% | 0.30% | -6.6% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $858,000 | -91.7% | 341,779 | -55.2% | 0.28% | -90.7% |
| ACET | New | ADICET BIO INC | $803,000 | – | 67,577 | +100.0% | 0.26% | – |
| AXGT | Sell | AXOVANT SCIENCES LTD | $790,000 | -72.1% | 171,083 | -83.0% | 0.26% | -68.6% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $784,000 | +5.0% | 6,600 | 0.0% | 0.26% | +18.1% | |
| PRVL | PREVAIL THERAPEUTICS INC | $764,000 | -31.7% | 75,000 | 0.0% | 0.25% | -23.2% | |
| ARDX | Sell | ARDELYX INC | $759,000 | -40.7% | 144,650 | -21.7% | 0.25% | -33.1% |
| NXTC | Buy | NEXTCURE INC | $748,000 | +74.4% | 85,000 | +325.0% | 0.24% | +96.0% |
| NTUS | NATUS MEDICAL INC | $735,000 | -21.5% | 42,900 | 0.0% | 0.24% | -11.5% | |
| KRTX | KARUNA THERAPEUTICS INC | $714,000 | -30.6% | 9,231 | 0.0% | 0.23% | -21.9% | |
| MASI | MASIMO CORPORATION | $708,000 | +3.5% | 3,000 | 0.0% | 0.23% | +16.8% | |
| SCPH | Sell | SCPHARMACEUTICALS INC | $677,000 | -8.0% | 90,900 | -9.1% | 0.22% | +3.8% |
| DMAC | New | DIAMEDICA THERAPEUTICS INC | $664,000 | – | 156,529 | +100.0% | 0.22% | – |
| CHMA | New | CHIASMA INC | $659,000 | – | 153,208 | +100.0% | 0.21% | – |
| ASMB | ASSEMBLY BIOSCIENCES INC | $585,000 | -29.5% | 35,573 | 0.0% | 0.19% | -20.8% | |
| GMDA | GAMIDA CELL LTD | $581,000 | -9.2% | 140,000 | 0.0% | 0.19% | +2.2% | |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $522,000 | +122.1% | 199,425 | +159.7% | 0.17% | +150.0% |
| ZYME | Sell | ZYMEWORKS INC | $463,000 | -28.9% | 9,950 | -44.8% | 0.15% | -19.7% |
| INGN | INOGEN INC | $435,000 | -18.4% | 15,000 | 0.0% | 0.14% | -8.4% | |
| RDUS | RADIUS HEALTH INC | $249,000 | -17.0% | 22,000 | 0.0% | 0.08% | -6.9% | |
| HOOK | Sell | HOOKIPA PHARMA INC | $209,000 | -77.6% | 22,061 | -72.5% | 0.07% | -74.7% |
| ASLN | ASLAN PHARMACEUTICALS LTDads | $164,000 | -4.7% | 86,082 | 0.0% | 0.05% | +6.0% | |
| LCTX | LINEAGE CELL THERAPEUTICS INC | $89,000 | +7.2% | 95,000 | 0.0% | 0.03% | +20.8% | |
| CRDF | New | CARDIFF ONCOLOGY INC | $71,000 | – | 5,000 | +100.0% | 0.02% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -6,100 | -100.0% | -0.02% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -157,700 | -100.0% | -0.08% | – |
| GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -50,000 | -100.0% | -0.10% | – |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -25,000 | -100.0% | -0.10% | – |
| ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -450,000 | -100.0% | -0.15% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -275,000 | -100.0% | -0.17% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -165,600 | -100.0% | -0.17% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -46,183 | -100.0% | -0.20% | – |
| MORF | Exit | MORPHIC HOLDING INC | $0 | – | -30,000 | -100.0% | -0.23% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -403,597 | -100.0% | -0.24% | – |
| CERC | Exit | CERECOR INC | $0 | – | -318,000 | -100.0% | -0.24% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -372,500 | -100.0% | -0.24% | – |
| CRBP | Exit | CORBUS PHARMACEUTICALS HLDGS | $0 | – | -108,061 | -100.0% | -0.26% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -64,235 | -100.0% | -0.30% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -524,664 | -100.0% | -0.35% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -50,749 | -100.0% | -0.40% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -23,210 | -100.0% | -0.43% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -21,893 | -100.0% | -0.72% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.